Table 1 Baseline characteristics
From: Aortic prosthetic size predictor in aortic valve replacement
| Variable | Cohort (n = 144) |
|---|---|
| Demographic variables | |
| Age (years) | 56.2 ± 14.6 |
| Sex (female) | 60 (41.6) |
| Comorbidities, n (%) | |
| Hypertension | 65 (45.1) |
| Type II diabetes mellitus | 31 (21.5) |
| Preoperative atrial fibrillation | 49 (34.0) |
| AVR variables | |
| Etiology of aortic valve lesions, n (%) | |
| Post rheumatic | 31 (21.5) |
| Degenerative | 51 (35.4) |
| Congenital | 62 (43.1) |
| Approach | |
| Full sternotomy | 68 (47.2) |
| Upper ministernotomy | 47 (32.6) |
| Second intercostal minithoracotomy | 29 (20.1) |
| Prosthesis type | |
| Mechanical valve | 62 (43.1) |
| Tissue valve | 82 (56.9) |
| Valve size (mm), mean ± SD | 21.36 ± 1.8 |
| Mechanical valve | 21.2 ± 1.77 |
| Tissue valve | 21.5 ± 1.74 |